Fate Therapeutics Inc’s recently made public that its Director Xu Yuan unloaded Company’s shares for reported $2678.0 on Aug 06 ’24. In the deal valued at $4.23 per share,633 shares were sold. As a result of this transaction, Xu Yuan now holds 8,669 shares worth roughly $22799.469999999998.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Xu Yuan bought 633 shares, generating $2,678 in total proceeds.
Before that, Dulac Edward J III sold 2,447 shares. Fate Therapeutics Inc shares valued at $19,013 were divested by the Chief Financial Officer at a price of $7.77 per share. As a result of the transaction, Dulac Edward J III now holds 101,479 shares, worth roughly $0.27 million.
BofA Securities upgraded its Fate Therapeutics Inc [FATE] rating to a Neutral from a an Underperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who increased its forecast for the stock in mid June from “a Neutral” to “an Overweight”. H.C. Wainwright revised its rating on January 24, 2023. It rated FATE as “a Neutral” which previously was an “a Buy”.
Price Performance Review of FATE
On Tuesday, Fate Therapeutics Inc [NASDAQ:FATE] saw its stock fall -11.15% to $2.63. Over the last five days, the stock has gained 8.68%. Fate Therapeutics Inc shares have fallen nearly -29.68% since the year began. Nevertheless, the stocks have fallen -0.75% over the past one year. While a 52-week high of $8.83 was reached on 03/07/24, a 52-week low of $1.96 was recorded on 11/15/24. SMA at 50 days reached $2.83, while 200 days put it at $4.27.
Levels Of Support And Resistance For FATE Stock
The 24-hour chart illustrates a support level at 2.48, which if violated will result in even more drops to 2.33. On the upside, there is a resistance level at 2.88. A further resistance level may holdings at 3.12. The Relative Strength Index (RSI) on the 14-day chart is 49.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.47, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.49%. Stochastics %K at 62.34% indicates the stock is a holding.
How much short interest is there in Fate Therapeutics Inc?
A steep rise in short interest was recorded in Fate Therapeutics Inc stocks on 2024-11-15, dropping by -5.67 million shares to a total of 10.39 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 16.06 million shares. There was a decline of -54.63%, which implies that there is a negative sentiment for the stock.
